share_log

PAVmed Q4 EPS $(0.15) Beats $(0.25) Estimate, Sales $112.00K Miss $270.00K Estimate

Benzinga ·  Mar 15, 2023 12:59

PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.25) by 40 percent. This is unchanged from the same period last year. The company reported quarterly sales of $112.00 thousand which missed the analyst consensus estimate of $270.00 thousand by 58.52 percent. This is a 62.67 percent decrease over sales of $300.00 thousand the same period last year.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment